IFNB1 and Sepsis: Indeed, it has been demonstrated that neutralization of proinflammatory mediators such as TNF-α and IFN-β during the hyperinflammation phase of sepsis and boost suppressed immunity with IFN-β during the immunosuppression phase both showed therapeutic effects [11].